Oncology Drug Pipeline Analysis Market Is Driven By Rising Cancer Prevalence The Global Oncology Drug Pipeline Analysis Market is estimated to be valued at US$ 216.81 Mn in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the oncology drug pipeline analysis market are B. Braun SE, Stryker Corporation, Adeor Medical Ag, Medtronic, Allotech Co. Ltd., Arthrex Inc., Brasseler USA, ClearPoint...
0 aandelen
1190 Views
0 voorbeeld